海外の治験の状況「1」での検索結果
860件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)
- Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction
- Australia, Brazil, Canada, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Romania, Russian Federation, Spain, Taiwan, Thailand, Turkey, United Kingdom, United States
- 2015-12-04
Not recruiting
- Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
- Gastric Adenocarcinoma
- Australia, Belgium, Chile, Colombia, Czech Republic, Czechia, France, Germany, Hungary, Italy, Peru, Poland, Romania, Spain, Turkey, United Kingdom, United States
- 2015-09-08
Not Recruiting
- A phase 4 clinical study to compare the safety and efficacy of LONQUEX® with NEULASTA® and Placebo in patients with Non-Small-Cell Lung Cancer treated with first-line chemotherapy
- Advanced squamous or non-squamous non-small-cell lung cancer (NSCLC) Stage IIIB/IV MedDRA version: 20.0 Level: PT Classification code 10029522 Term: Non-small cell lung cancer stage IV System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: PT Classification code 10029521 Term: Non-small cell lung cancer stage IIIB System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Belarus, Bosnia and Herzegovina, Brazil, Bulgaria, Chile, Croatia, Czech Republic, Greece, Hungary, Latvia, Mexico, Poland, Romania, Russian Federation, Serbia, Slovakia, South Africa, Spain, Turkey, Ukraine
- 2015-03-17
Not recruiting
- Cetuximab Combined With Irinotecan in First-line Therapy for Metastatic Colorectal Cancer (CRYSTAL)
- Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer;Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer;Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer;Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer
- Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Chile, Czech Republic, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Israel, Italy, Korea, Republic of, Mexico, Netherlands, Poland, Romania, Russian Federation, Singapore, Slovakia, South Africa, Spain, Sweden, Taiwan, Turkey, Ukraine, United Kingdom
- 2005-09-08
Not recruiting
- Dose Ranging Study of the GLP-1 Agonist AVE0010 in Metformin-Treated Subjects With Type 2 Diabetes Mellitus
- Type 2 Diabetes
- Argentina, Brazil, Bulgaria, Canada, Chile, Croatia, Mexico, Poland, Romania, Russian Federation, Ukraine, United States
- 2006-03-06
Not Recruiting
- PHASE IIA STUDY OF DB289 FOR THE SECOND LINE TREATMENT OF PNEUMONYSIS CARINII PNEUMOCYSTIS IN PATIENTS WITH HIV INFECTION.
- -B24 Unspecified human immunodeficiency virus [HIV] disease Unspecified human immunodeficiency virus [HIV] disease;Unspecified human immunodeficiency virus [HIV] disease
- Peru
- 2002-03-19
Not recruiting
- A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer
- Colorectal Cancer;Colorectal Cancer;Colorectal Cancer;Colorectal Cancer
- Australia, Austria, Brazil, Canada, China, Czech Republic, Denmark, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Ireland, Israel, Italy, Korea, Republic of, Mexico, New Zealand, Norway, Panama, Portugal, Puerto Rico, Russian Federation, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, United Kingdom, United States
- 2003-09-15
Not recruiting
- Pemetrexed as First Line Chemotherapy for Advanced Breast Cancer
- Breast Cancer
- Argentina, Belgium, Germany, Romania, Spain, United Kingdom
- 2003-07-28
Not recruiting
- A Phase II Trial of Triapine (NSC #663249) in Combination With Gemcitabine as Second Line Treatment of Non-Small Cell Lung Cancer
- Recurrent Non-small Cell Lung Cancer
- Australia, Peru, Puerto Rico, South Africa, United States
- 2004-02-10
Not recruiting
- A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
- Non-Small Cell Lung Cancer;Non-Small Cell Lung Cancer;Non-Small Cell Lung Cancer;Non-Small Cell Lung Cancer
- Argentina, Australia, Belgium, Brazil, Bulgaria, Hong Kong, Israel, Italy, Mexico, Philippines, Romania, Singapore, Spain, Taiwan, Thailand, United Kingdom, United States
- 2005-11-21
